OLVCX
Price
$18.86
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
4.91B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

OLVCX vs RMEBX

Header iconOLVCX vs RMEBX Comparison
Open Charts OLVCX vs RMEBXBanner chart's image
JPMorgan Large Cap Value C
Price$18.86
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets4.91B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
OLVCX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OLVCX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OLVCX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. OLVCX (4.91B). RMEBX pays higher dividends than OLVCX: RMEBX (1.16) vs OLVCX (0.57). OLVCX was incepted earlier than RMEBX: OLVCX (26 years) vs RMEBX (11 years). OLVCX (1.50) is less costly to investors than RMEBX (1.07). OLVCX is a more actively managed with annual turnover of: 167.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than OLVCX: RMEBX (250) vs OLVCX (1000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. OLVCX (-1.34). RMEBX return over 5 years is better than : 49.85 vs. OLVCX (43.10).
OLVCXRMEBXOLVCX / RMEBX
Total Expense Ratio1.441.07135%
Annual Report Gross Expense Ratio1.501.07140%
Fund Existence26 years11 years-
Gain YTD-0.3275.349-6%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.91B105B5%
Annual Yield % from dividends0.571.1649%
Returns for 1 year-1.348.30-16%
Returns for 3 years2.9117.9616%
Returns for 5 years43.1049.8586%
Returns for 10 years35.3268.2152%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA